Literature DB >> 2860136

Efficacy of propranolol in neuroleptic-induced akathesia.

L Adler, B Angrist, E Peselow, J Corwin, J Rotrosen.   

Abstract

The effects of propranolol, 20 to 30 mg/day, on neuroleptic-induced akathesia were compared with those of lorazepam, 2 mg/day, and periods of no treatment. Raters were blind to treatment condition. As reported in prior open studies, propranolol was found to be dramatically effective in reducing akathesia induced by neuroleptic treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860136

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  12 in total

1.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

2.  Propranolol treatment for neuroleptic-induced akathisia.

Authors:  Ashish Sharma; Vishal Madaan; Frederick Petty
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  The syndrome of motor restlessness--a treatable but under-recognised disorder.

Authors:  A Bakheit
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 4.  Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Authors:  P Turner
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

Review 5.  Neuroleptic-induced akathisia: a review.

Authors:  L A Adler; B Angrist; S Reiter; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  Managing antipsychotic-induced acute and chronic akathisia.

Authors:  C H Miller; W W Fleischhacker
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 7.  Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal.

Authors:  P Sachdev
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 8.  Adverse effects of antipsychotic drugs.

Authors:  A K Malhotra; R E Litman; D Pickar
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

Review 9.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 10.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.